Case Study: a UK-based biotech company secures pharma interest for oncology asset licensing with Evaluate

a UK-based biotech company achieves 30% response rates with Evaluate for oncology partner outreach

A UK-based biotech company needed to find partners to out-license two of its oncology assets but lacked the internal resources to identify and engage suitable targets after previous efforts fell short. They engaged Evaluate’s Business Development & Licensing consulting team to address this challenge.

Evaluate implemented a data-driven approach, using proprietary databases to build a model that prioritized over 1,000 potential partners. They then executed a tailored outreach campaign to the top 50 targets. This strategy yielded a 30% response rate and resulted in three major pharma companies actively reviewing the assets for licensing.